An Indian-origin doctor and a nurse were charged in an indictment for their roles in unlawfully distributing controlled substances.
Hemal Mehta, 49 and Heather Marks, 36, of Tennessee were charged in an indictment filed last week in the Middle District of Tennessee with one count of conspiracy to unlawfully distribute controlled substances and nine counts of unlawful distribution of controlled substances, Assistant Attorney General Brian Benczkowski of the Justice Department's Criminal Division said.
According to the indictment, between 2016 and 2018, Mehta and Marks, whom Mehta supervised, conspired to distribute controlled substances, including oxycodone, morphine sulfate and oxymorphone, to patients outside the usual course of professional practice and without a legitimate medical purpose.
Mehta and Marks also allegedly dispensed and distributed oxycodone and oxymorphone on various occasions between 2016 and 2018.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
